Combination of Obestatin and Bone Marrow Mesenchymal Stem Cells Prevents Aggravation of Endocrine Pancreatic Damage in Type II Diabetic Rats

One of the new promising therapies in treatment of diabetes mellitus is mesenchymal stem cells (MSCs) which have an interesting therapeutic potentiality based on their paracrine effect and transdifferentiation potentiality. Also obestatin improves the generation of functional β cells/islet-like cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussien, Noha I, Ebrahim, Nesrine, Mohammed, Ola M, Sabry, Dina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741194/
https://www.ncbi.nlm.nih.gov/pubmed/29186652
http://dx.doi.org/10.15283/ijsc17035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741194/
https://www.ncbi.nlm.nih.gov/pubmed/29186652
http://dx.doi.org/10.15283/ijsc17035

Ejemplares similares